GlassScriptPhysician profile
Jennifer Supol
NPI 1003826900
$814.41
in general payments reported to CMS, 2019-2025
17 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $274 · 2020: $53.32 · 2021: $16.35 · 2022: $47.73 · 2023: $123 · 2024: $196 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $423.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $151.08 | 2019-2022 | |
| Corium, LLC | $131.35 | 2023-2024 | Azstarys |
| Alk-Abello, INC | $110.29 | 2024-2025 | Ragwitek, Grastek, Odactra |
| Biogen, INC. | $57.57 | 2022-2025 | Spinraza |
| Pfizer INC. | $54.85 | 2019 | |
| Ucb, INC. | $54.70 | 2022-2023 | Briviact |
| Sanofi-Aventis U.S. LLC | $41.65 | 2024-2025 | |
| Kaleo, INC. | $34.05 | 2019-2020 | |
| Sanofi Pasteur INC. | $32.34 | 2020-2021 | |
| Cranial Technologies, INC | $28.49 | 2019 | |
| Acadia Pharmaceuticals INC | $22.01 | 2024 | Daybue |
| Ultragenyx Pharmaceutical INC. | $21.45 | 2025 | Dojolvi |
| Astrazeneca Pharmaceuticals LP | $19.80 | 2024 | Flumist Quadrivalent |
| Hologic Sales and Service, LLC | $15.87 | 2019 | |
| Merck Sharp & Dohme LLC | $14.50 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $12.48 | 2019 | |
| Shire North American Group INC | $11.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Supol listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.